- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of August 2018
Here are the top 5 articles for the month of August.
Transcript:
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of August.
Number 5: In a survey, employers indicated that they are taking a more activist role in delivering healthcare to their employees. They also expressed frustration with the pharmaceutical supply chain and said they expect to see a large uptake of virtual healthcare in the coming years.
Number 4: Ohio announced that it will end its contracts with all of its pharmacy benefit managers and start over with transparent ones.
Number 3: CMS announced that it will end the so-called 25% rule for long-term care hospitals and approved add-on payments estimated to cost about 72 million dollars for CAR T-cell therapy.
Number 2: Celyad’s Investigational New Drug application for CYAD-101 received FDA approval, making it the first non—gene-edited allogeneic clinical program for CAR T-cell therapy.
Number 1: During the Office of the National Coordinator for Health IT’s second Interoperability Forum, CMS administrator Seema Verma painted a future where health data follows the patient and can be shared with a doctor at the click of a button.
To read all of these articles and more, visit AJMC.com.
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Challenges in GERD Diagnosis and Treatment: The Need for a Multidisciplinary Approach
January 10th 2025A recent review emphasizes the need for personalized treatment strategies and a multidisciplinary approach to effectively manage the various subtypes of gastroesophageal reflux disease (GERD), highlighting the challenges of diagnosis and treatment, particularly in cases with refractory symptoms.
Read More
